<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37431963</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.</ArticleTitle><Pagination><StartPage>e111719</StartPage><MedlinePgn>e111719</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e111719</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2022111719</ELocationID><Abstract><AbstractText>Aggregation of the RNA-binding protein TAR DNA-binding protein 43 (TDP-43) is the key neuropathological feature of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). In physiological conditions, TDP-43 is predominantly nuclear, forms oligomers, and is contained in biomolecular condensates assembled by liquid-liquid phase separation (LLPS). In disease, TDP-43 forms cytoplasmic or intranuclear inclusions. How TDP-43 transitions from physiological to pathological states remains poorly understood. Using a variety of cellular systems to express structure-based TDP-43 variants, including human neurons and cell lines with near-physiological expression levels, we show that oligomerization and RNA binding govern TDP-43 stability, splicing functionality, LLPS, and subcellular localization. Importantly, our data reveal that TDP-43 oligomerization is modulated by RNA binding. By mimicking the impaired proteasomal activity observed in ALS/FTLD patients, we found that monomeric TDP-43 forms inclusions in the cytoplasm, whereas its RNA binding-deficient counterpart aggregated in the nucleus. These differentially localized aggregates emerged via distinct pathways: LLPS-driven aggregation in the nucleus and aggresome-dependent inclusion formation in the cytoplasm. Therefore, our work unravels the origins of heterogeneous pathological species reminiscent of those occurring in TDP-43 proteinopathy patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published under the terms of the CC BY NC ND 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-Berlanga</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9064-9724</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wiersma</LastName><ForeName>Vera I</ForeName><Initials>VI</Initials><Identifier Source="ORCID">0000-0001-8223-4588</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zbinden</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7785-2741</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vos</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6675-6968</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foglieni</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurodegeneration Research Group, Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallona</LastName><ForeName>Izaskun</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2853-7526</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betz</LastName><ForeName>Katharina M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-5041-6205</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cl&#xe9;ry</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4550-6908</Identifier><AffiliationInfo><Affiliation>Department of Biology, Institute of Biochemistry, ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zhongning</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigort</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1686-3260</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Rossi</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2356-4269</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manglunia</LastName><ForeName>Ruchi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantardini</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahadevan</LastName><ForeName>Sonu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stach</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hruska-Plochan</LastName><ForeName>Marian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9253-4362</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>Frederic H-T</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Department of Biology, Institute of Biochemistry, ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paganetti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1896-6324</Identifier><AffiliationInfo><Affiliation>Neurodegeneration Research Group, Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polymenidou</LastName><ForeName>Magdalini</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1271-9445</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LLPS</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">oligomerization</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37431963</ArticleId><ArticleId IdType="pmc">PMC10476175</ArticleId><ArticleId IdType="doi">10.15252/embj.2022111719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Afroz T, Hock EM, Ernst P, Foglieni C, Jambeau M, Gilhespy LAB, Laferriere F, Maniecka Z, Pluckthun A, Mittl P et&#xa0;al (2017) Functional and dynamic polymerization of the ALS&#x2010;linked protein TDP&#x2010;43 antagonizes its pathologic aggregation. Nat Commun 8: 45</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, P&#xe9;rez&#x2010;Berlanga M, Polymenidou M (2019) Structural transition, function and dysfunction of TDP&#x2010;43 in neurodegenerative diseases. Chimia (Aarau) 73: 380&#x2013;390</Citation><ArticleIdList><ArticleId IdType="pubmed">31118120</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Reyes A, Huber W (2012) Detecting differential usage of exons from RNA&#x2010;seq data. Genome Res 22: 2008&#x2013;2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460195</ArticleId><ArticleId IdType="pubmed">22722343</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et&#xa0;al (2006) TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arganda&#x2010;Carreras I, Kaynig V, Rueden C, Eliceiri KW, Schindelin J, Cardona A, Sebastian Seung H (2017) Trainable Weka segmentation: a machine learning tool for microscopy pixel classification. Bioinformatics 33: 2424&#x2013;2426</Citation><ArticleIdList><ArticleId IdType="pubmed">28369169</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi&#x2010;Falcon B (2022) Structure of pathological TDP&#x2010;43 filaments from ALS with FTLD. Nature 601: 139&#x2013;143</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Stabile S, Vande Velde C (2012) Endogenous TDP&#x2010;43, but not FUS, contributes to stress granule assembly via G3BP. Mol Neurodegener 7: 54</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3502460</ArticleId><ArticleId IdType="pubmed">23092511</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenda&#xf1;o&#x2010;V&#xe1;zquez SE, Dhir A, Bembich S, Buratti E, Proudfoot N, Baralle FE (2012) Autoregulation of TDP&#x2010;43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 26: 1679&#x2013;1684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418585</ArticleId><ArticleId IdType="pubmed">22855830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE (2008) Structural determinants of the cellular localization and shuttling of TDP&#x2010;43. J Cell Sci 121: 3778&#x2013;3785</Citation><ArticleIdList><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avenda&#xf1;o&#x2010;V&#xe1;zquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E et&#xa0;al (2011) TDP&#x2010;43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker BM, Walker SC (2015) Fitting linear mixed&#x2010;effects models using lme4. J Stat Softw 10.18637/jss.v067.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289&#x2013;300</Citation></Reference><Reference><Citation>Boisvert F&#x2010;M, Hendzel MJ, Bazett&#x2010;Jones DP (2000) Promyelocytic leukemia (Pml) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148: 283&#x2013;292</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174275</ArticleId><ArticleId IdType="pubmed">10648561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30: 2114&#x2013;2120</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Boveris A, Navarro A (2008) Brain mitochondrial dysfunction in aging. IUBMB Life 60: 308&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pubmed">18421773</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP&#x2010;43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276: 36337&#x2013;36343</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA et&#xa0;al (2007) TDP&#x2010;43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171: 227&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu TH, Wu CY, Chiang MH, Toh EK, Hsu YC, Lin KF, Liao YH, Huang TH, Huang JJ (2012) The N&#x2010;terminus of TDP&#x2010;43 promotes its oligomerization and enhances DNA binding affinity. Biochem Biophys Res Commun 425: 219&#x2013;224</Citation><ArticleIdList><ArticleId IdType="pubmed">22835933</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H&#x2010;J, Topp SD, Hui HS, Zacco E, Katarya M, McLoughlin C, King A, Smith BN, Troakes C, Pastore A et&#xa0;al (2019) RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP&#x2010;43 proteinopathy. Brain 142: 3753&#x2013;3770</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen&#x2010;Plotkin AS, Lee VM, Trojanowski JQ (2010) TAR DNA&#x2010;binding protein 43 in neurodegenerative disease. Nat Rev Neurol 6: 211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chujo T, Yamazaki T, Hirose T (2016) Architectural RNAs (arcRNAs): a class of long noncoding RNAs that function as the scaffold of nuclear bodies. Biochim Biophys Acta 1859: 139&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">26021608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP&#x2010;43 function and aggregation propensity. Nat Commun 6: 5845</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS mutations disrupt phase separation mediated by alpha&#x2010;helical structure in the TDP&#x2010;43 low&#x2010;complexity C&#x2010;terminal domain. Structure 24: 1537&#x2013;1549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Dignon GL, Zerze GH, Schmidt HB, D'Ordine AM, Kim YC, Rohatgi R, Ayala YM, Mittal J, Fawzi NL (2020) TDP&#x2010;43 &#x3b1;&#x2010;helical structure tunes liquid&#x2013;liquid phase separation and function. Proc Natl Acad Sci U S A 117: 5883&#x2013;5894</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.&#x2010;range mass accuracies and proteome&#x2010;wide protein quantification. Nat Biotechnol 12: 1367&#x2013;1372</Citation><ArticleIdList><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Baskerville V, Zaepfel BL, Dickson DW, Rigo F, Bennett F, Lusk CP, Rothstein JD (2021) Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP&#x2010;43 dysfunction in sporadic and familial ALS. Sci Transl Med 13: eabe1923</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9022198</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrogio A, Buratti E, Stuani C, Guarnaccia C, Romano M, Ayala YM, Baralle FE (2009) Functional mapping of the interaction between TDP&#x2010;43 and hnRNP A2 in vivo. Nucleic Acids Res 37: 4116&#x2013;4126</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709582</ArticleId><ArticleId IdType="pubmed">19429692</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rossi P, Lewis AJ, Furrer J, De Vos L, Demeter T, Zbinden A, Zhong W, Wiersma VI, Scialo C, Weber J et&#xa0;al (2021) FTLD&#x2010;TDP assemblies seed neoaggregates with subtype&#x2010;specific features via a prion&#x2010;like cascade. EMBO Rep 22: e53877</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8647015</ArticleId><ArticleId IdType="pubmed">34806807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G (2012) TDP&#x2010;43 aggregation in neurodegeneration: are stress granules the key? Brain Res 1462: 16&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA&#x2010;seq aligner. Bioinformatics 29: 15&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rrbaum AR, Kochen L, Langer JD, Schuman EM (2018) Local and global influences on protein turnover in neurons and glia. Elife 7: e34202</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6008053</ArticleId><ArticleId IdType="pubmed">29914620</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L, Zaepfel BL, Aksenova V, Dasso M, Rothstein JD, Kalab P, Hayes LR (2022) Nuclear RNA binding regulates TDP&#x2010;43 nuclear localization and passive nuclear export. Cell Rep 40: 111106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9345261</ArticleId><ArticleId IdType="pubmed">35858577</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;ster R, Kaltheuner IH, Schmitz M, Geyer M (2021) 1,6&#x2010;hexanediol, commonly used to dissolve liquid&#x2010;liquid phase separated condensates, directly impairs kinase and phosphatase activities. J Biol Chem 296: 100260</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948595</ArticleId><ArticleId IdType="pubmed">33814344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Funk C, Abou&#x2010;Ajram C, Hutten S, Funk EBE, Kehlenbach RH, Bailer SM, Dormann D (2018) Nuclear egress of TDP&#x2010;43 and FUS occurs independently of Exportin&#x2010;1/CRM1. Sci Rep 8: 7084</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eersel J, Ke YD, Gladbach A, Bi M, G&#xf6;tz J, Kril JJ, Ittner LM (2011) Cytoplasmic accumulation and aggregation of TDP&#x2010;43 upon proteasome inhibition in cultured neurons. PloS One 6: e22850</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146516</ArticleId><ArticleId IdType="pubmed">21829535</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim H&#x2010;J, Hart MP, Chen&#x2010;Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM et&#xa0;al (2010) Ataxin&#x2010;2 intermediate&#x2010;length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069&#x2013;1075</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, Li X, Malik AM, Martinez J, Beg AA, Barmada SJ (2019) An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43&#x2010;dependent neurodegeneration. Cell Rep 27: 1133&#x2013;1150</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Foglieni C, Papin S, Salvade A, Afroz T, Pinton S, Pedrioli G, Ulrich G, Polymenidou M, Paganetti P (2017) Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD&#x2010;related proteins. Sci Rep 7: 14013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656600</ArticleId><ArticleId IdType="pubmed">29070802</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster AD, Flynn LL, Cluning C, Cheng F, Davidson JM, Lee A, Polain N, Mejzini R, Farrawell N, Yerbury JJ et&#xa0;al (2021) p62 overexpression induces TDP&#x2010;43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death. Sci Rep 11: 11474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169680</ArticleId><ArticleId IdType="pubmed">34075102</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouquet C, Gilles J&#x2010;F, Heck N, Dos Santos M, Schwartzmann R, Cannaya V, Morel M&#x2010;P, Davidson RS, Trembleau A, Bolte S (2015) Improving axial resolution in confocal microscopy with new high refractive index mounting media. PloS One 10: e0121096</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4379090</ArticleId><ArticleId IdType="pubmed">25822785</ArticleId></ArticleIdList></Reference><Reference><Citation>French RL, Grese ZR, Aligireddy H, Dhavale DD, Reeb AN, Kedia N, Kotzbauer PT, Bieschke J, Ayala YM (2019) Detection of TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) oligomers as initial intermediate species during aggregate formation. J Biol Chem 294: 6696&#x2013;6709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F, Schueder F, Tiwary S, Gupta R, K&#xf6;rner R, Schlichthaerle T, Cox J, Jungmann R, Hartl FU, Hipp MS (2019) The nucleolus functions as a phase&#x2010;separated protein quality control compartment. Science 365: 342&#x2013;347</Citation><ArticleIdList><ArticleId IdType="pubmed">31296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher PS, Clowes Candadai SV, Gardner RG (2014) The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility. J Cell Sci 127: 1980&#x2013;1991</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4004975</ArticleId><ArticleId IdType="pubmed">24569878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset&#x2010;Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, Cleveland DW (2019) Cytoplasmic TDP&#x2010;43 De&#x2010;mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP&#x2010;43, and cell death. Neuron 102: 339&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallegger M, Chakrabarti AM, Lee FCY, Lee BL, Amalietti AG, Odeh HM, Copley KE, Rubien JD, Portz B, Kuret K et&#xa0;al (2021) TDP&#x2010;43 condensation properties specify its RNA&#x2010;binding and regulatory repertoire. Cell 184: 4680&#x2013;4696</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445024</ArticleId><ArticleId IdType="pubmed">34380047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et&#xa0;al (2008) Phosphorylated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64: 60&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, De Assis DR, Vourc'h P, Andres CR, Corcia P, Lanznaster D, Blasco H (2019) The debated toxic role of aggregated TDP&#x2010;43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 142: 1176&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiji M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T, Matsumoto M (2008) White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP&#x2010;43&#x2010;immunopositive inclusions co&#x2010;localize with p62, but not ubiquitin. Acta Neuropathol 116: 183&#x2013;191</Citation><ArticleIdList><ArticleId IdType="pubmed">18584184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruska&#x2010;Plochan M, Betz KM, Ronchi S, Wiersma VI, Maniecka Z, Hock E&#x2010;M, Laferriere F, Sahadevan S, Hoop V, Delvendahl I et&#xa0;al (2021) Human neural networks with sparse TDP&#x2010;43 pathology reveal NPTX2 misregulation in ALS/FTLD. bioRxiv 10.1101/2021.12.08.471089 [PREPRINT]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.08.471089</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumikawa K, Nobe Y, Ishikawa H, Yamauchi Y, Taoka M, Sato K, Nakayama H, Simpson RJ, Isobe T, Takahashi N (2019) TDP&#x2010;43 regulates site&#x2010;specific 2&#x2032;&#x2010;O&#x2010;methylation of U1 and U2 snRNAs via controlling the Cajal body localization of a subset of C/D scaRNAs. Nucleic Acids Res 47: 2487&#x2013;2505</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412121</ArticleId><ArticleId IdType="pubmed">30759234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraj GG, Hipp MS, Hartl FU (2020) Functional modules of the Proteostasis network. Cold Spring Harb Perspect Biol 12: a033951</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942124</ArticleId><ArticleId IdType="pubmed">30833457</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L&#x2010;L, Xue W, Hong J&#x2010;Y, Zhang J&#x2010;T, Li M&#x2010;J, Yu S&#x2010;N, He J&#x2010;H, Hu H&#x2010;Y (2017) The N&#x2010;terminal dimerization is required for TDP&#x2010;43 splicing activity. Sci Rep 7: 6196</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883&#x2013;1898</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD&#x2010;U subtypes. Acta Neuropathol 118: 349&#x2013;358</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044602</ArticleId><ArticleId IdType="pubmed">19455346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S, Maharana S, Alberti S (2017) Hexanediol: a chemical probe to investigate the material properties of membrane&#x2010;less compartments. Matters 3: e201702000010</Citation></Reference><Reference><Citation>Kuznetsova A, Brockhoff PB, Christensen RHB (2017) lmerTest package: tests in linear mixed effects models. J Stat Softw 82 10.18637/jss.v082.i13</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v082.i13</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferriere F, Maniecka Z, Perez&#x2010;Berlanga M, Hruska&#x2010;Plochan M, Gilhespy L, Hock EM, Wagner U, Afroz T, Boersema PJ, Barmettler G et&#xa0;al (2019) TDP&#x2010;43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci 22: 65&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh ER, Kwong LK, Elman L, Grossman M, Lee VMY, Irwin DJ et&#xa0;al (2017) Expansion of the classification of FTLD&#x2010;TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134: 65&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Asress S, Hales CM, Gearing M, Vizcarra JC, Fournier CN, Gutman DA, Chin L&#x2010;S, Li L, Glass JD (2019) TDP&#x2010;43 cytoplasmic inclusion formation is disrupted in C9orf72&#x2010;associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Brain Commun 1: fcz014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788139</ArticleId><ArticleId IdType="pubmed">31633109</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30: 923&#x2013;930</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Albuquerque CP, Han JS, Lagier&#x2010;Tourenne C, Tokunaga S, Zhou H, Cleveland DW (2010) ALS&#x2010;associated mutations in TDP&#x2010;43 increase its stability and promote TDP&#x2010;43 complexes with FUS/TLS. Proc Natl Acad Sci U S A 107: 13318&#x2013;13323</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC (2015) TDP&#x2010;43 repression of nonconserved cryptic exons is compromised in ALS&#x2010;FTD. Science 349: 650&#x2013;655</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA&#x2010;seq data with DESeq2. Genome Biol 15: 550</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, Baralle FE, Damberger FF, Allain FH (2013) Molecular basis of UG&#x2010;rich RNA recognition by the human splicing factor TDP&#x2010;43. Nat Struct Mol Biol 20: 1443&#x2013;1449</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guill&#xe9;n&#x2010;Boixet J, Franzmann TM et&#xa0;al (2018) RNA buffers the phase separation behavior of prion&#x2010;like RNA binding proteins. Science 360: 918&#x2013;921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik S, Kundu S (2018) Topology and oligomerization of mono&#x2010; and oligomeric proteins regulate their half&#x2010;lives in the cell. Structure 26: 869&#x2013;878</Citation><ArticleIdList><ArticleId IdType="pubmed">29804822</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis&#x2010;Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ et&#xa0;al (2019) RNA binding antagonizes neurotoxic phase transitions of TDP&#x2010;43. Neuron 102: 321&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Inobe T, Amano T, Murai K, Nukina N, Mori N (2018) N&#x2010;Acyldopamine induces aggresome formation without proteasome inhibition and enhances protein aggregation via p62/SQSTM1 expression. Sci Rep 8: 9585</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018635</ArticleId><ArticleId IdType="pubmed">29941919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M, Romano V, Pantoja&#x2010;Uceda D, Stuani C, Baralle FE, Buratti E, Laurents DV (2017) Point mutations in the N&#x2010;terminal domain of transactive response DNA&#x2010;binding protein 43 kDa (TDP&#x2010;43) compromise its stability, dimerization, and functions. J Biol Chem 292: 11992&#x2013;12006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512090</ArticleId><ArticleId IdType="pubmed">28566288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C et&#xa0;al (2019) Limbic&#x2010;predominant age&#x2010;related TDP&#x2010;43 encephalopathy (LATE): consensus working group report. Brain 142: 1503&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et&#xa0;al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS (2007) TDP&#x2010;43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66: 152&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">17279000</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Frick P, Paron F, Kosten J, Buratti E, Mackenzie IR (2020) Antibody against TDP&#x2010;43 phosphorylated at serine 375 suggests conformational differences of TDP&#x2010;43 aggregates among FTLD&#x2010;TDP subtypes. Acta Neuropathol 140: 645&#x2013;658</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547034</ArticleId><ArticleId IdType="pubmed">32778941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S, Suyama S, Kuwako K, Imai T, Murayama S et&#xa0;al (2013) The long non&#x2010;coding RNA nuclear&#x2010;enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain 6: 31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SH, Wu F, Harrich D, Garcia&#x2010;Martinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP&#x2010;43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69: 3584&#x2013;3596</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SS, Belmont BJ, Sante JM, Rexach MF (2007) Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell 129: 83&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">17418788</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdikari TM, Murthy AC, Fawzi NL (2022) Molecular insights into the effect of alkanediols on FUS liquid&#x2010;liquid phase separation. bioRxiv 10.1101/2022.05.05.490812 [PREPRINT]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.05.490812</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi ES, Ca&#x11f;atay T, Fung HYJ, Li YC, Chook YM, Thomas PJ (2018) Active nuclear import and passive nuclear export are the primary determinants of TDP&#x2010;43 localization. Sci Rep 8: 7083</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C et&#xa0;al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano V, Quadri Z, Baralle FE, Buratti E (2015) The structural integrity of TDP&#x2010;43 N&#x2010;terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion 9: 1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4601194</ArticleId><ArticleId IdType="pubmed">25635624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rot G, Wang Z, Huppertz I, Modic M, Len&#x10d;e T, Hallegger M, Haberman N, Curk T, von Mering C, Ule J (2017) High&#x2010;resolution RNA maps suggest common principles of splicing and polyadenylation regulation by TDP&#x2010;43. Cell Rep 19: 1056&#x2013;1067</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437728</ArticleId><ArticleId IdType="pubmed">28467899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaguri H, Chew J, Xu YF, Gendron TF, Garrett A, Lee CW, Jansen&#x2010;West K, Bauer PO, Perkerson EA, Tong J et&#xa0;al (2016) The extreme N&#x2010;terminus of TDP&#x2010;43 mediates the cytoplasmic aggregation of TDP&#x2010;43 and associated toxicity in vivo. Brain Res 1647: 57&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003772</ArticleId><ArticleId IdType="pubmed">27155453</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda&#x2010;Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et&#xa0;al (2012) Fiji: an open&#x2010;source platform for biological&#x2010;image analysis. Nat Methods 9: 676&#x2013;682</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL, Lee Y&#x2010;B, Chen H&#x2010;J, Urwin H, Sardone V, Mitchell JC, Rogelj B, Rubinsztein DC et&#xa0;al (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP&#x2010;43 species. J Cell Sci 127: 1263&#x2013;1278</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, Kukharsky MS, An H, Dimasi P, Alexeeva S, Shabir O, Heath PR, Buchman VL (2018) Protective paraspeckle hyper&#x2010;assembly downstream of TDP&#x2010;43 loss of function in amyotrophic lateral sclerosis. Mol Neurodegener 13: 30</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevtsov SP, Dundr M (2011) Nucleation of nuclear bodies by RNA. Nat Cell Biol 13: 167&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pubmed">21240286</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Bose P, Leong&#x2010;Quong RYY, Fujita DJ, Riabowol K (2010) REAP: a two minute cell fractionation method. BMC Res Notes 3: 294</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993727</ArticleId><ArticleId IdType="pubmed">21067583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V et&#xa0;al (2011) Characterizing the RNA targets and position&#x2010;dependent splicing regulation by TDP&#x2010;43. Nat Neurosci 14: 452&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H, Iguchi Y, Furuya A, Kataoka A, Hatsuta H, Atsuta N, Tanaka F, Hashizume Y, Akatsu H, Murayama S et&#xa0;al (2013) Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol Med 5: 221&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M et&#xa0;al (2012) Molecular analysis and biochemical classification of TDP&#x2010;43 proteinopathy. Brain 135: 3380&#x2013;3391</Citation><ArticleIdList><ArticleId IdType="pubmed">23035040</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;rker C, Akal F, Joho D, Panse C, Barkow&#x2010;Oesterreicher S, Rehrauer H, Schlapbach R (2010) B&#x2010;Fabric: the Swiss army knife for life sciences. In Proceedings of the 13th International Conference on Extending Database Technology, pp 717&#x2013;720. New York, NY: Association for Computing Machinery;</Citation></Reference><Reference><Citation>Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA (2012) Ivermectin is a specific inhibitor of importin &#x3b1;/&#x3b2;&#x2010;mediated nuclear import able to inhibit replication of HIV&#x2010;1 and dengue virus. Biochem J 443: 851&#x2013;856</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3327999</ArticleId><ArticleId IdType="pubmed">22417684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Chang HY, Hou SC, Liou GG, Way TD, James Shen CK (2012) The self&#x2010;interaction of native TDP&#x2010;43 C terminus inhibits its degradation and contributes to early proteinopathies. Nat Commun 3: 766</Citation><ArticleIdList><ArticleId IdType="pubmed">22473010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, Nourse A, Ramirez Montero D, Ryan VH, Rohatgi R et&#xa0;al (2018) A single N&#x2010;terminal phosphomimic disrupts TDP&#x2010;43 polymerization, phase separation, and RNA splicing. EMBO J 37: e97452</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Lim L, Dang M, Song J (2019) A novel mechanism for ATP to enhance the functional oligomerization of TDP&#x2010;43 by specific binding. Biochem Biophys Res Commun 514: 809&#x2013;814</Citation><ArticleIdList><ArticleId IdType="pubmed">31079926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Duan Y, Duan G, Wang Q, Zhang K, Deng X, Qian B, Gu J, Ma Z, Zhang S et&#xa0;al (2020) Stress induces dynamic, cytotoxicity&#x2010;antagonizing TDP&#x2010;43 nuclear bodies via paraspeckle LncRNA NEAT1&#x2010;mediated liquid&#x2010;liquid phase separation. Mol Cell 79: 443&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Inami H, Oiwa K, Murata Y, Sakai S, Komine O, Sobue A, Iguchi Y, Katsuno M, Yamanaka K (2020) Aggresome formation and liquid&#x2013;liquid phase separation independently induce cytoplasmic aggregation of TAR DNA&#x2010;binding protein 43. Cell Death Dis 11: 909</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585435</ArticleId><ArticleId IdType="pubmed">33097688</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbance of nuclear and cytoplasmic TAR DNA&#x2010;binding protein (TDP&#x2010;43) induces disease&#x2010;like redistribution, sequestration, and aggregate formation. J Biol Chem 283: 13302&#x2013;13309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Lu S, Gasior K, Singh D, Vazquez&#x2010;Sanchez S, Tapia O, Toprani D, Beccari MS, Yates JR, Da Cruz S et&#xa0;al (2021) HSP70 chaperones RNA&#x2010;free TDP&#x2010;43 into anisotropic intranuclear liquid spherical shells. Science 371: eabb4309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zbinden A, P&#xe9;rez&#x2010;Berlanga M, De Rossi P, Polymenidou M (2020) Phase separation and neurodegenerative diseases: a disturbance in the force. Dev Cell 55: 45&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">33049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Caulfield T, Xu YF, Gendron TF, Hubbard J, Stetler C, Sasaguri H, Whitelaw EC, Cai S, Lee WC et&#xa0;al (2013) The dual functions of the extreme N&#x2010;terminus of TDP&#x2010;43 in regulating its biological activity and inclusion formation. Hum Mol Genet 22: 3112&#x2013;3122</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>